These medications are not intended as a shortcut
On average, 1 in 2 users paused or stopped their medication within the first 4 months
This GLP-1 nutrition support stack helps maintain sufficient protein intake , provides digestive support , and covers daily micronutrient needs when appetite is lower
[5] [2] Patients starting GLP-1 therapy should be aware of: Potential mood changes during the adjustment period, particularly if experiencing significant gastrointestinal side effects The importance of continuing existing mental health treatments unless advised otherwise by their healthcare team Realistic expectations regarding weight loss and metabolic improvements, as unrealistic goals can lead to disappointment Healthcare professionals prescribing GLP-1 agonists should: Screen for depression and anxiety at baseline and during follow-up appointments Monitor for mood changes , particularly in patients with pre-existing mental health conditions Ensure coordinated care between diabetes/obesity services and mental health teams when appropriate It is essential to recognise that GLP-1 agonists are not a substitute for evidence-based depression treatments, including psychological therapies and antidepressant medications when indicated
Values are provided as published reference figures for research identification
Rising demand for effective weight reduction strategies and improved glycemic control, especially in regions facing surging rates of metabolic disorders, is a key factor driving market expansion
